Cipla, Dr Reddy’s, Viatris And Teva Named In US Revlimid Antitrust Suit
ANDA Sponsors ‘Restrained Competition And Maintained Shared Monopoly’
Defendant Dr Reddy's says the suit is without merit • Source: Shutterstock (Andriy Popov / Alamy Stock Photo/Alamy Stock Photo) 
